The product life cycle, or time path of sales, of many high-tech goods and services is bell-shaped. I show that product life cycles endogenously arise in markets with rapid technological innovations, are heterogeneous across products, and are affected by the level of market competition.…Read More
The pharmaceutical industry leads all industries in terms of R&D spend. Portfolio management in new drug development is extremely challenging due to long drug development cycles and high probabilities of failure.…Read More
How do alliance portfolios evolve? We develop grounded theory based on Unisys’ case, which reveals how exogenous technological changes at the industry level and shifts in a firm’s strategy shape the composition of partners and the nature of alliance relationships.…Read More
The construct of novelty is an important primitive for theories of organization learning, strategic change, and innovation. The organizational pursuit of novelty is generally theorized as necessary for long-term organizational adaptation and survival yet variance increasing in the short term.…Read More
